Porphyria cutanea tarda exacerbation as a paraneoplastic syndrome in vaginal cancer resolved with chemoradiation [PDF]
Gynecologic Oncology Reports, 2021 Porphyria Cutanea Tarda (PCT) is a rare paraneoplastic syndrome. The effects of therapeutic ionizing radiation in patients with PCT are not well understood.
Sarah Z. Hazell +2 more
doaj +3 more sources
Porphyria Cutanea Tarda Associated With Acute Hemorrhagic Pancreatitis [PDF]
Journal of Investigative Medicine High Impact Case Reports, 2019 Porphyria cutanea tarda (PCT) is a condition of dysregulated heme synthesis that leads to accumulation of photosensitizing precursors with resultant fragility and blistering of the skin.
Manasi Singh MD +2 more
doaj +4 more sources
Precipitating factors of porphyria cutanea tarda in Brazil with emphasis on hemochromatosis gene (HFE) mutations. Study of 60 patients [PDF]
Anais Brasileiros de Dermatologia, 2013 BACKGROUND: Porphyria cutanea tarda is the most common form of porphyria, characterized by the decreased activity of the uroporphyrinogen decarboxylase enzyme.
Fatima Mendonca Jorge Vieira +4 more
doaj +3 more sources
Scleral Necrosis in Porphyria Cutanea Tarda: A Case Report [PDF]
Journal of Clinical and Diagnostic Research, 2022 Scleral necrosis is a rare but well documented ocular manifestation of Porphyria Cutanea Tarda (PCT). The PCT is caused by a deficiency of Uroporphyrinogen Decarboxylase (Uro-D).
Ruchi Shukla +2 more
doaj +2 more sources
Case Report: Treatment of porphyria cutanea tarda with low dose hydroxychloroquine [version 1; peer review: 1 approved, 2 approved with reservations] [PDF]
F1000Research, 2022 Background: Porphyria cutanea tarda (PCT) is a complex metabolic disease resulting from altered activity of the enzyme uroporphyrinogen decarboxylase (UROD) in the liver resulting in accumulation of uroporphyrin.
Alexander Nirenberg +2 more
doaj +2 more sources
Porphyria cutanea tarda: a case report [PDF]
Journal of Medical Case Reports, 2019 Background The porphyrias are a rare group of metabolic disorders that can either be inherited or acquired. Along the heme biosynthetic pathway, porphyrias can manifest with neurovisceral and/or cutaneous symptoms, depending on the defective enzyme ...
Hanife Usta Atmaca, Feray Akbas
doaj +2 more sources
Secondary hemosiderosis presented by porphyria cutanea tarda in a kidney dialysis patient: A case report [PDF]
SAGE Open Medical Case Reports, 2020 A 68-year-old woman with chronic kidney disease receiving dialysis and iron supplementation presented to our hospital with painful blisters, fragile skin, and changes to skin pigmentation on the dorsal side of both upper and lower limbs.
Farjah H AlGahtani +2 more
doaj +2 more sources
Dorsal Hand Involvement in Porphyria Cutanea Tarda
Acta Médica Portuguesan/a.
Gilberto Pires da Rosa +2 more
doaj +3 more sources
The diagnosis and management of porphyria cutanea tarda (PCT) [PDF]
South African Family Practice, 2009 The porphyrias are a group of disorders in which excessive quantities of porphyrins or their precursors are produced. They are due to abnormalities in the control of the porphyrin-haem metabolic pathway.
Mojakgomo H. Motswaledi
doaj +2 more sources
Porphyria cutanea tarda and Sjogren's syndrome [PDF]
Anais Brasileiros de Dermatologia, 2014 Porphyria cutanea tarda is prevalent in connective tissue disease, common in systemic lupus erythematosus. However, the co-existence of primary sjogren's syndrome and porphyria cutanea tarda is rare and poses diagnostic and therapeutic challenges.
Su Fang +4 more
doaj +2 more sources